128 related articles for article (PubMed ID: 38582032)
1. An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillance.
Lantsman T; Jansen C; Larson E; Esselen K; Shea M
Cancer Treat Res Commun; 2024; 39():100812. PubMed ID: 38582032
[TBL] [Abstract][Full Text] [Related]
2. Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125.
Lee JY; Kim JH; Seo JW; Kim HS; Kim JW; Park NH; Song YS
Int J Gynecol Cancer; 2016 Oct; 26(8):1434-9. PubMed ID: 27465903
[TBL] [Abstract][Full Text] [Related]
3. Patterns and utility of routine surveillance in high grade endometrial cancer.
Hunn J; Tenney ME; Tergas AI; Bishop EA; Moore K; Watkin W; Kirschner C; Hurteau J; Rodriguez GC; Lengyel E; Lee NK; Yamada SD
Gynecol Oncol; 2015 Jun; 137(3):485-9. PubMed ID: 25838164
[TBL] [Abstract][Full Text] [Related]
4. Post treatment surveillance of type II endometrial cancer patients.
Zakhour M; Li AJ; Walsh CS; Cass I; Karlan BY; Rimel BJ
Gynecol Oncol; 2013 Dec; 131(3):609-12. PubMed ID: 24051222
[TBL] [Abstract][Full Text] [Related]
5. Use of Aggressive Surveillance for Locoregional Endometrial Cancer After Local Therapy.
Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.
Lou F; Huang J; Sima CS; Dycoco J; Rusch V; Bach PB
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):75-81; discussion 81-2. PubMed ID: 23127371
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.
Kiran G; Kesterson JP; Ozerkan K; Kanis M; Groman A; Lele S
Eur J Gynaecol Oncol; 2013; 34(6):522-6. PubMed ID: 24601043
[TBL] [Abstract][Full Text] [Related]
8. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
9. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR
J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702
[TBL] [Abstract][Full Text] [Related]
10. Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?
Lennox GK; Clark M; Zigras T; Rouzbahman M; Han G; Bernardini MQ; Gien LT
J Obstet Gynaecol Can; 2021 May; 43(5):564-570. PubMed ID: 33412305
[TBL] [Abstract][Full Text] [Related]
11. Surveillance Imaging in Patients With Endometrial Cancer in First Remission.
Alabed YZ; Cheng SC; Mudge C; Sakellis C; Van den Abbeele AD; Campos SM; Jacene HA
Curr Probl Diagn Radiol; 2018 Sep; 47(5):311-316. PubMed ID: 28917433
[TBL] [Abstract][Full Text] [Related]
12. Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
Subramanian M; Liu J; Greenberg C; Schumacher J; Chang GJ; McMurry TL; Francescatti AB; Semenkovich TR; Hudson JL; Meyers BF; Puri V; Kozower BD
J Thorac Cardiovasc Surg; 2019 Mar; 157(3):1205-1217.e2. PubMed ID: 31130741
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of risk factors for recurrence after treatment of endometrial uterine cancer].
Zalewski K; Rzepka J; Madry R; Dańska-Bidzińska A; Bidzinski M
Ginekol Pol; 2009 Sep; 80(9):687-93. PubMed ID: 19886243
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of intensive surveillance practices adopted for endometrial cancer survivors.
Nakamura K; Kitahara Y; Yamashita S; Kigure K; Ito I; Nishimura T; Azuma A; Kanuma T
BMC Womens Health; 2022 Aug; 22(1):355. PubMed ID: 35999573
[TBL] [Abstract][Full Text] [Related]
15. Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study.
Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
Int J Gynecol Cancer; 2019 Mar; 29(3):497-504. PubMed ID: 30833438
[TBL] [Abstract][Full Text] [Related]
16. Recurrence patterns and surveillance for patients with early stage endometrial cancer.
Salani R; Nagel CI; Drennen E; Bristow RE
Gynecol Oncol; 2011 Nov; 123(2):205-7. PubMed ID: 21820709
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Bristow RE; Purinton SC; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL
Gynecol Oncol; 2006 Nov; 103(2):709-13. PubMed ID: 16797686
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.
Belhocine T; De Barsy C; Hustinx R; Willems-Foidart J
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1132-9. PubMed ID: 12192557
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
20. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
